dorsaVi launches industry-first 3D motion analysis test for ACL injuries

dorsaVi (ASX: DVL) has launched a first-in-class 3D motion analysis test for the early identification and prevention of anterior cruciate ligament (ACL) injuries in athletes.

The commercially available knee assessment tool employs advanced artificial intelligence capabilities within the company’s wearable sensor technology to identify unique movement patterns linked to ACL injury risk.

The company believes the 3D knee assessment test represents a major advancement over industry-standard one-dimensional (1D) force plates, which measure vertical force but fail to capture the critical rotational torque forces that place athletes at risk.

Proactive prevention

dorsaVi chief executive officer Dr Andrew Ronchi said the innovation brings real-time laboratory-grade analysis into the hands of clinicians and coaches, enabling proactive injury prevention and rehabilitation strategies at scale.

“Our AI-driven 3D motion analysis offers unprecedented accuracy in assessing knee mechanics in the clinic, which is something the industry has never had access to outside of biomechanics labs,” he said.

Real-time feedback eliminates the need for expensive and time-consuming lab assessments, while actionable insights from a large dataset of knee assessments allow practitioners to benchmark an athlete’s movement against established norms and intervene before injury occurs.

“We believe this innovation will become the new standard in ACL injury prevention and rehabilitation, delivering tangible benefits for athletes, teams and clinicians worldwide.”

Major challenge

ACL injuries represent a major challenge for athletes, sports teams and healthcare providers worldwide, as they often require lengthy rehabilitation and costly surgical intervention and can cost millions of dollars in lost player time.

More than 200,000 ACL injuries are recorded each year in the US alone across a range of sports, at an estimated annual cost of $7 billion.

Until now, accurately measuring knee rotation and torque — key risk factors for ACL tears — has only been possible in specialised biomechanics labs.

Dr Ronchi said the company would also target broader musculoskeletal health applications associated with cost-saving preventative injury screening by insurers and employers.